Board decisions will benefit the health of women and children in developing countries GAVI Alliance DHAKA, 17 November 2011 – Responding to demand from developing countries, the GAVI Alliance will take the first steps towards the introduction of human papillomavirus (HPV) and rubella vaccines in developing countries, the GAVI Board announced on Thursday. If negotiations […]
The world’s first cancer vaccine
Transhuman Medicine admin on Oct 30, 2011 • 7:47 am The world’s first vaccine designed to prevent cancer was not developed by a pharmaceutical company. Instead, its development was funded by public institutions on two continents, including three universities, and the U.S. National Cancer Institute. The vaccine prevents human papillomavirus (HPV), an ailment that […]
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
British Medical Journal BMJ 2010; 340:c712 doi: 10.1136/bmj.c712 (Published 2 March 2010) Cite this as: BMJ 2010; 340:c712 Abstract Objective To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage. Design Pooled analysis of two multicentre, phase three masked randomised controlled trials Setting Multicentre trials in several continents and in Costa Rica. […]